Evidence map›Paper›PMID 36181583›Full record

ReviewMetabolomics : Official journal of the Metabolomic Society2022

Single cell metabolism: current and future trends.

Ahmed Ali, Shawn Davidson, Ernest Fraenkel, Ian Gilmore, Thomas Hankemeier, Jennifer A Kirwan, Andrew N Lane, Ingela Lanekoff, Mioara Larion, Laura-Isobel McCall and 3 more

Abstract readReview
In one paragraph

Review in Metabolomics : Official journal of the Metabolomic Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Advanced Microfluidics for Single Cell-Based Cancer Research.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high-sucrose diet-mediated gut barrier dysfunction.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ahmed AliLeiden Academic Centre for Drug Research, University of Leiden, Gorlaeus Building Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Shawn DavidsonLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
Ernest FraenkelDepartment of Biological Engineering and the Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.
Ian GilmoreNational Physical Laboratory, Teddington, TW11 0LW, Middlesex, UK.
Thomas HankemeierLeiden Academic Centre for Drug Research, University of Leiden, Room number GW4.07, Gorlaeus Building, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Jennifer A KirwanBerlin Institute of Health, Metabolomics Platform, Translational Research Unit of the Charite-Universitätsmedizin Berlin, Anna-Louisa-Karsch-Str 2, 10178, Berlin, Germany.
Andrew N LaneDepartment of Toxicology and Cancer Biology, and Center for Environmental and Systems Biochemistry, University of Kentucky, 789 S. Limestone St, Lexington, KY, 40536, USA. andrew.lane@uky.edu.
Ingela LanekoffDepartment of Chemistry-BMC, Uppsala University, Husargatan 3 (576), 751 23, Uppsala, Sweden.
Mioara LarionCenter for Cancer Research, National Cancer Institute, Building 37, Room 1136A, Bethesda, MD, 20892, USA.
Laura-Isobel McCallDepartment of Chemistry & Biochemistry, Department of Microbiology and Plant Biology, Laboratories of Molecular Anthropology and Microbiome Research, University of Oklahoma, 101 Stephenson Parkway, room 3750, Norman, OK, 73019-5251, USA.
Michael MurphyDepartments of Biological Engineering, Department of Electrical Engineering, and Computer Science and the Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, USA.
Jonathan V SweedlerDepartment of Chemistry, and the Beckman Institute, University of Illinois Urbana-Champaign, 505 South Mathews Avenue, Urbana, IL, 61801, USA.
Caigang ZhuDepartment of Biomedical Engineering, University of Kentucky, Lexington, KY, 40536, USA.

Funding

University of Kentucky Center for Cancer MetabolismP20GM121327 · NIGMS · UNIVERSITY OF KENTUCKY · PI Binhua P Zhou · 2017 to 2026
$25.0M
The UIUC Neuroproteomics Center on Cell-Cell SignalingP30DA018310 · NIDA · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI Jonathan V. Sweedler · 2004 to 2026
$24.9M
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.R01AI168038 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Kathryn Marie Jones · 2022 to 2026
$3.8M
UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
Small molecule biomarkers of cardiac Chagas disease progressionR21AI156669 · NIAID · UNIVERSITY OF OKLAHOMA · PI BOWMAN, NATALIE MCCARTER, GILMAN, ROBERT H · 2021 to 2022
$458k
Oral carnitine administration as a novel treatment for chronic-stage Chagas diseaseR21AI148886 · NIAID · UNIVERSITY OF OKLAHOMA · PI MCCALL, LAURA-ISOBEL · 2020 to 2021
$426k
NIAID NIH HHS R01 AI168038NIAID NIH HHS R21 AI148886NIAID NIH HHS R21 AI156669NIAID NIH HHS R25 AI147376NIDA NIH HHS P30 DA018310NIGMS NIH HHS P20 GM121327
6 · The paper itself

Abstract

Single cell metabolomics is an emerging and rapidly developing field that complements developments in single cell analysis by genomics and proteomics. Major goals include mapping and quantifying the metabolome in sufficient detail to provide useful information about cellular function in highly heterogeneous systems such as tissue, ultimately with spatial resolution at the individual cell level. The chemical diversity and dynamic range of metabolites poses particular challenges for detection, identification and quantification. In this review we discuss both significant technical issues of measurement and interpretation, and progress toward addressing them, with recent examples from diverse biological systems. We provide a framework for further directions aimed at improving workflow and robustness so that such analyses may become commonly applied, especially in combination with metabolic imaging and single cell transcriptomics and proteomics.

Indexed as

MetabolomeMetabolomicsProteomicsWorkflowMetabolic imagingSingle cell metabolismSpatial metabolomics

Identifiers

PMID36181583
PMCPMC10063251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.